The biological activities of sesterterpenoid-type ophiobolins

Marine Drugs

Volumn 15, Issue 7, 2017, Pages

  Tian, Wei ^a   Deng, Zixin ^a   Hong, Kui ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Bioactivities; Mechanisms; Ophiobolins; Source; Structure activity relationship

Indexed keywords

18 DIHYDROOPHIOBOLIN C; 3 ANHYDRO 6 EPI OPHIOBOLIN A; 3 ANHYDRO 6 EPI OPHIOBOLIN B; 3 ANHYDRO 6 HYDROXY OPHIOBOLIN A; 3 ANHYDROOPHIOBOLIN A; 6 EPI OPHIOBOLIN A; 6 EPI OPHIOBOLIN C; 6 EPI OPHIOBOLIN G; 6 EPI OPHIOBOLIN L; 6 EPI OPHIOBOLIN M; OPHIOBOLIN A; OPHIOBOLIN A LACTONE; OPHIOBOLIN B; OPHIOBOLIN B LACTONE; OPHIOBOLIN C; OPHIOBOLIN D; OPHIOBOLIN DERIVATIVE; OPHIOBOLIN E; OPHIOBOLIN F; OPHIOBOLIN G; OPHIOBOLIN H; OPHIOBOLIN I; OPHIOBOLIN J; OPHIOBOLIN K; OPHIOBOLIN L; OPHIOBOLIN M; OPHIOBOLIN N; OPHIOBOLIN O; TERPENOID DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; OPHIOBOLINS; SESTERTERPENE;

ANTIFUNGAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BARLEY; BIOSYNTHESIS; CABBAGE; CYTOTOXICITY; DRUG POTENCY; HUMAN; MAIZE; MELANOMA; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHOTOSYNTHESIS; PHYTOTOXICITY; QUADRUPOLE MASS SPECTROMETRY; REVIEW; SORGHUM; SORGHUM HALEPENSE; SOYBEAN; STEREOCHEMISTRY; STRUCTURE ACTIVITY RELATION; TAXONOMY; TOBACCO; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY; XANTHIUM; ANIMAL; CANCER STEM CELL; DRUG EFFECTS; MULTIDRUG RESISTANCE;

ANIMALS; DRUG RESISTANCE, MULTIPLE; HUMANS; NEOPLASTIC STEM CELLS; SESTERTERPENES; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 85024494032     PISSN: None     EISSN: 16603397     Source Type: Journal    
DOI: 10.3390/md15070229     Document Type: Review

References (87)

1. Evidente, A.; Kornienko, A.; Cimmino, A.; Andolfi, A.; Lefranc, F.; Mathieu, V.; Kiss, R. Fungal metabolites with anticancer activity. Nat. Prod. Rep. 2014, 31, 617–627.
2. Ebada, S.S.; Proksch, P. Marine-derived fungal metabolites. In Springer Handbook of Marine Biotechnology; Kim, S.K., Ed.; Springer: Berlin/Heidelberg, Germany, 2015; pp. 759–788.
3. Tommonaro, G.; Rosa, S.D.; Carnuccio, R.; Maiuri, M.C.; Stefano, D.D. Marine sponge sesterpenoids as potent apoptosis-inducing factors in human carcinoma cell lines. In Handbook of Anticancer Drugs from Marine Origin; Kim, S.K., Ed.; Springer: Berlin/Heidelberg, Germany, 2015; pp. 439–479.
4. Evidente, A.; Kornienko, A.; Lefranc, F.; Cimmino, A.; Dasari, R.; Evidente, M.; Mathieu, V.; Kiss, R. Sesterterpenoids with anticancer activity. Curr. Med. Chem. 2015, 22, 3502–3522.
5. Wang, L.; Yang, B.; Lin, X.P.; Zhou, X.F.; Liu, Y. Sesterterpenoids. Nat. Prod. Rep. 2013, 30, 455–473.
6. Zhang, H.; Dong, M.; Wang, H.; Crews, P. Secondary metabolites from the marine sponge genus Phyllospongia. Mar. Drugs 2017, 15, 12.
7. Zhang, D.; Fukuzawa, S.; Satake, M.; Li, X.; Kuranaga, T.; Niitsu, A.; Yoshizawa, K.; Tachibana, K. Ophiobolin O and 6-epi-ophiobolin O, two new cytotoxic sesterterpenes from the marine derived fungus Aspergillus sp. Nat. Prod. Commun. 2012, 7, 1411–1414.
8. Nakamura, M.; Ishibashi, K. On the new antibiotics “Ophiobolin”, produced by Ophiobolus miyabeanus. J. Agric. Chem. Soc. Jpn. 1958, 32, 739–744.
9. Au, T.K.; Chick, W.S.; Leung, P.C. The biology of ophiobolins. Life Sci. 2000, 67, 733–742.
10. Tipton, C.L.; Paulsen, P.V.; Betts, R.E. Effects of ophiobolin a on ion leakage and hexose uptake by maize roots. Plant Physiol. 1977, 59, 907–910.
11. Ohkawa, H.; Tamura, T. Studies on the metabolites of Cochliobolus miyabeanus. Agric. Biol. Chem. 1966, 30, 285–291.
12. Evidente, A.; Andolfi, A.; Cimmino, A.; Vurro, M.; Fracchiolla, M.; Charudattan, R. Herbicidal potential of ophiobolins produced by Drechslera gigantea. J. Agric. Food Chem. 2006, 54, 1779–1783.
13. Sugawara, F.; Strobel, G.; Strange, R.N.; Siedow, J.N.; Van Duyne, G.D.; Clardy, J. Phytotoxins from the pathogenic fungi Drechslera maydis and Drechslera sorghicola. Proc. Natl. Acad. Sci. USA 1987, 84, 3081–3085.
14. Xiao, J.Z.; Tsuda, M.; Doke, N.; Nishimura, S. Phytotoxins produced by germinating spores of Bipolaris oryzae. Phytopathology 1991, 81, 58–64.
15. Kim, H.J.; Kim, J.C.; Kim, B.S.; Kim, H.G.; Cho, K.Y. Antibiotic and phytotoxic activities of Ophiobolins from Helminthosporium species. Plant Pathol. J. 1999, 15, 14–20.
16. Mandal, S.M.; Roy, A.; Paul, D.; Korpole, S.; Shrivastava, S.L.; Chakraborty, R.; Basak, A. Fungi fights fungi: Tip-off in antifungal chemotherapy. In Recent Trends in Antifungal Agents and Antifungal Therapy; Basak, A., Chakraborty, R., Mandal, S.M., Eds.; Springer: Delhi, India, 2016; pp. 1–27.
17. Li, G.H.; Zhang, K.Q. Nematode-toxic fungi and their nematicidal metabolites. In Nematode-Trapping Fungi; Zhang, K.Q., Hyde, K.D., Eds.; Fungal Diversity Research Series; Springe: Berlin, Germany, 2014; pp. 313–375.
18. Tsipouras, A.; Adefarati, A.A.; Tkacz, J.S.; Frazier, E.G.; Rohrer, S.P.; Birzin, E.; Rosegay, A.; Zink, D.L.; Goetz, M.A.; Singh, S.B.; et al. Ophiobolin M and analogues, noncompetitive inhibitors of ivermectin binding with nematocidal activity. Bioorg. Med. Chem. 1996, 4, 531–536.
19. De Carvalho, C.R.; Vieira, M.D.L.A.; Cantrell, C.L.; Wedge, D.E.; Alves, T.M.A.; Zani, C.L.; Pimenta, R.S.; Sales Junior, P.A.; Murta, S.M.F.; Romanha, A.J.; et al. Biological activities of ophiobolin K and 6-epi-ophiobolin K produced by the endophytic fungus Aspergillus calidoustus. Nat. Prod. Res. 2016, 30, 478–481.
20. Sun, W.; Lv, C.; Zhu, T.; Yang, X.; Wei, S.; Sun, J.; Hong, K.; Zhu, W.; Huang, C. Ophiobolin-O reverses adriamycin resistance via cell cycle arrest and apoptosis sensitization in adriamycin-resistant human breast carcinoma (MCF-7/ADR) cells. Mar. Drugs 2013, 11, 4570–4584.
21. Bury, M.; Novo-Uzal, E.; Andolfi, A.; Cimini, S.; Wauthoz, N.; Heffeter, P.; Lallemand, B.; Avolio, F.; Delporte, C.; Cimmino, A.; et al. Ophiobolin A, a sesterterpenoid fungal phytotoxin, displays higher in vitro growth-inhibitory effects in mammalian than in plant cells and displays in vivo antitumor activity. Int. J. Oncol. 2013, 43, 575–585.
22. Wang, S.; Luo, X.; Yan, R.; Wang, Q.; Qi, Q.; Chi, X.; Zhang, L.; Yu, Z.; Cai, B.; Chen, J.L.; et al. 3-Anhydro-6-hydroxy-ophiobolin A displays high in vitro and in vivo efficacy against influenza A virus infection. Protein Cell 2016, 7, 839–843.
23. Pósa, A.; Szabó, R.; Szalai, Z.; Kupai, K.; Deim, Z.; Murlasits, Z.; Bencsik, O.; Szekeres, A.; Vágvölgyi, C.; Balogh, L.; et al. The effect of acute ophiobolin A treatment on HO-mediated inflammatory processes. Hum. Exp. Toxicol. 2016, 36, 594–602.
24. Bladt, T.T.; Dürr, C.; Knudsen, P.B.; Kildgaard, S.; Frisvad, J.C.; Gotfredsen, C.H.; Seiffert, M.; Larsen, T.O. Bio-activity and dereplication-based discovery of ophiobolins and other fungal secondary metabolites targeting leukemia cells. Molecules 2013, 18, 14629–14650.
25. Kildgaard, S.; Mansson, M.; Dosen, I.; Klitgaard, A.; Frisvad, J.C.; Larsen, T.O.; Nielsen, K.F. Accurate dereplication of bioactive secondary metabolites from marine-derived fungi by UHPLC-DAD-QTOFMS and a MS/HRMS library. Mar. Drugs 2014, 12, 3681–3705.
26. Wei, H.; Itoh, T.; Kinoshita, M.; Nakai, Y.; Kurotaki, M.; Kobayashi, M. Cytotoxic sesterterpenes, 6-epi-ophiobolin G and 6-epi-ophiobolin N, from marine derived fungus Emericella variecolor GF10. Tetrahedron 2004, 60, 6015–6019.
27. Arai, M.; Niikawa, H.; Kobayashi, M. Marine-derived fungal sesterterpenes, ophiobolins, inhibit biofilm formation of Mycobacterium species. J. Nat. Med. 2013, 67, 271–275.
28. Evidente, A.; Andolfi, A.; Cimmino, A.; Vurro, M.; Fracchiolla, M.; Charudattan, R.; Motta, A. Ophiobolin E and 8-epi-ophiobolin J produced by Drechslera gigantea, a potential mycoherbicide of weedy grasses. Phytochemistry 2006, 67, 2281–2287.
29. Wang, Q.X.; Bao, L.; Yang, X.L.; Liu, D.L.; Guo, H.; Dai, H.Q.; Song, F.H.; Zhang, L.X.; Guo, L.D.; Li, S.J.; et al. Ophiobolins P–T, five new cytotoxic and antibacterial sesterterpenes from the endolichenic fungus Ulocladium sp. Fitoterapia 2013, 90, 220–227.
30. Li, E.; Clark, A.M.; Rotella, D.P.; Hufford, C.D. Microbial metabolites of ophiobolin A and antimicrobial evaluation of ophiobolins. J. Nat. Prod. 1995, 58, 74–81.
31. Jayasuriya, H.; Herath, K.B.; Ondeyka, J.G.; Polishook, J.D.; Bills, G.F.; Dombrowski, A.W.; Springer, M.S.; Siciliano, S.; Malkowitz, L.; Sanchez, M.; et al. Isolation and structure of antagonists of chemokine receptor (CCR5). J. Nat. Prod. 2004, 67, 1036–1038.
32. Itai, A.; Nozoe, S. Structure and chemistry of some ophiobolin D derivatives. Chem. Pharm. Bull. 1980, 28, 1043–1050.
33. Phuwapraisirisan, P.; Sawang, K.; Siripong, P.; Tip-pyang, S. Anhydrocochlioquinone A, a new antitumor compound from Bipolaris oryzae. Tetrahedron Lett. 2007, 38, 5193–5195.
34. Sugawara, F.; Takahashi, N.; Strobel, G.; Yun, C.H.; George, G.; Fu, Y.; Clardy, J. Some new phytotoxic ophiobolins produced by Drechslera oryzae. J. Org. Chem. 1988, 53, 2170–2172.
35. Shen, X.; Krasnoff, S.B.; Lu, S.W.; Dunbar, C.D.; O’Neal, J.; Turgeon, B.G.; Yoder, O.C.; Gibson, D.M.; Hamann, M.T. Characterization of 6-epi-3-anhydroophiobolin B from Cochliobolus heterostrophus. J. Nat. Prod. 1999, 62, 895–897.
36. Ahn, J.W.; Lee, M.K.; Choi, S.U.; Lee, C.O.; Kim, B.S. Cytotoxic ophiobolins produced by Bipolaris sp. J. Microbiol. Biotechnol. 1998, 8, 406–408.
37. Zhao, X.L.; Niu, Y.C.; Deng, H.; Luo, D.Q. Secondary metabolites from Bipolaris setariae NY1 strain. Mycosystema 2013, 32, 286–291.
38. Wang, Q.X.; Yang, J.L.; Qi, Q.Y.; Bao, L.; Yang, X.L.; Liu, M.M.; Huang, P.; Zhang, L.X.; Chen, J.L.; Cai, L.; et al. 3-Anhydro-6-hydroxy-ophiobolin A, a new sesterterpene inhibiting the growth of methicillin-resistant Staphylococcus aureus and inducing the cell death by apoptosis on K562, from the phytopathogenic fungus Bipolaris oryzae. Bioorg. Med. Chem. Lett. 2013, 23, 3547–3550.
39. + exchange in maize coleoptile tissues. Planta 1979, 146, 271–274.
40. Bladt, T.T.; Frisvad, J.C.; Knudsen, P.B.; Larsen, T.O. Anticancer and antifungal compounds from Aspergillus, Penicillium and other filamentous fungi. Mol. Basel Switz. 2013, 18, 11338–11376.
41. Akihiko, K.; Shigeo, N.; Shigenobu, O. Subcellular distribution of sesterterpene- and sterol-biosynthesizing activities in Cochliobolus heterostrophus. Biochim. Biophys. Acta BBA-Lipids Lipid Metab. 1973, 296, 615–623.
42. Nozoe, S.; Morisaki, M. Enzymic formation of a tricyclic sesterterpene alcohol from mevalonic acid and all-trans-geranylfarnesyl pyrophosphate. Chem. Commun. 1969, 22, 1319–1320.
43. Liu, X.H.; Miao, F.P.; Qiao, M.F.; Cichewicz, R.H.; Ji, N.Y. Terretonin, ophiobolin, and drimane terpenes with absolute configurations from an algicolous Aspergillus ustus. RSC Adv. 2013, 3, 588–595.
44. Cutler, H.G.; Crumley, F.G.; Cox, R.H.; Springer, J.P.; Arrendale, R.F.; Cole, R.J.; Cole, P.D. Ophiobolins G and H: New fungal metabolites from a novel source, Aspergillus ustus. J. Agric. Food Chem. 1984, 32, 778–782.
45. Liu, H.B.; Edrada-Ebel, R.; Ebel, R.; Wang, Y.; Schulz, B.; Draeger, S.; Müller, W.E.G.; Wray, V.; Lin, W.H.; Proksch, P. Ophiobolin sesterterpenoids and pyrrolidine alkaloids from the sponge-derived fungus Aspergillus ustus. Helv. Chim. Acta 2011, 94, 623–631.
46. Zhu, W.M.; Lu, Z.Y.; Hong, K.; Miao, C. The Preparation and Application of Sesterterpenoids Compounds Ophiobolins. CN Patent 101591314, 2 December 2009.
47. Proksch, P.; Ebel, R.; Edrada, R.; Riebe, F.; Liu, H.; Diesel, A.; Bayer, M.; Li, X.; Lin, W.H.; Grebenyuk, V.; et al. Sponge-associated fungi and their bioactive compounds: The suberites case. Bot. Mar. 2008, 51, 209–218.
48. Singh, S.B.; Smith, J.L.; Sabnis, G.S.; Dombrowski, A.W.; Schaeffer, J.M.; Goetz, M.A.; Bills, G.F. Structure and conformation of ophiobolin K and 6-epi-ophiobolin K from Aspergillus ustus as a nematocidal agent. Tetrahedron 1991, 47, 6931–6938.
49. Grunewald, S.; Kriegel, C.; Baumann, T.; Glander, H.J.; Paasch, U. Interactions between apoptotic signal transduction and capacitation in human spermatozoa. Hum. Reprod. 2009, 24, 2071–2078.
50. Locato, V.; Uzal, E.N.; Cimini, S.; Zonno, M.C.; Evidente, A.; Micera, A.; Foyer, C.H.; Gara, L.D. Low concentrations of the toxin ophiobolin A lead to an arrest of the cell cycle and alter the intracellular partitioning of glutathione between the nuclei and cytoplasm. J. Exp. Bot. 2015, 66, 2991–3000.
51. Kumar, K.V.K.; Reddy, M.S.; Kloepper, J.W.; Lawrence, K.S.; Zhou, X.G.; Groth, D.E.; Zhang, S.; Rao, R.S.; Wang, Q.; Raju, M.R.B.; et al. Commercial potential of microbial inoculants for sheath blight management and yield enhancement of rice. In Bacteria in Agrobiology: Crop Ecosystems; Maheshwari, D.K., Ed.; Springer: Berlin/Heidelberg, Germany, 2011; pp. 237–264.
52. Dallagnol, L.J.; Rodrigues, F.A.; Martins, S.C.V.; Cavatte, P.C.; DaMatta, F.M. Alterations on rice leaf physiology during infection by Bipolaris oryzae. Australas. Plant Pathol. 2011, 40, 360–365.
53. Chattopadhyay, A.K.; Samaddar, K.R. Effects of Helminthosporium oryzae infection and ophiobolin on the cell membranes of host tissues. Physiol. Plant Pathol. 1976, 8, 131–139.
54. Dallagnol, L.J.; Martins, S.C.V.; DaMatta, F.M.; Rodrigues, F.Á. Brown spot negatively affects gas exchange and chlorophyll a fluorescence in rice leaves. Trop. Plant Pathol. 2015, 40, 275–278.
55. Leung, P.C.; Taylor, W.A.; Wang, J.H.; Tipton, C.L. Ophiobolin A, A natural product inhibitor of calmodulin. J. Biol. Chem. 1984, 259, 2742–2747.
56. Leung, P.C.; Graves, L.M.; Tipton, C.L. Characterization of the interaction of ophiobolin A and calmodulin. Int. J. Biochem. 1988, 20, 1351–1359.
57. Krizsán, K.; Bencsik, O.; Nyilasi, I.; Galgóczy, L.; Vágvölgyi, C.; Papp, T. Effect of the sesterterpene-type metabolites, ophiobolins A and B, on zygomycetes fungi. FEMS Microbiol. Lett. 2010, 313, 135–140.
58. De Vries-van Leeuwen, I.J.; Kortekaas-Thijssen, C.; Nzigou Mandouckou, J.A.; Kas, S.; Evidente, A.; de Boer, A.H. Fusicoccin-A selectively induces apoptosis in tumor cells after interferon-α priming. Cancer Lett. 2010, 293, 198–206.
59. Bencsik, O.; Papp, T.; Berta, M.; Zana, A.; Forgó, P.; Dombi, G.; Andersson, M.A.; Salkinoja-Salonen, M.; Vágvölgyi, C.; Szekeres, A. Ophiobolin A from Bipolaris oryzae perturbs motility and membrane integrities of porcine sperm and induces cell death on mammalian somatic cell lines. Toxins 2014, 6, 2857–2871.
60. Fujiwara, H.; Matsunaga, K.; Kumagai, H.; Ishizuka, M.; Ohizumi, Y. Ophiobolin A, a novel apoptosis-inducing agent from fungus strain f-7438. Pharm. Pharmacol. Commun. 2000, 6, 427–431.
61. Bhatia, D.R.; Dhar, P.; Mutalik, V.; Deshmukh, S.K.; Verekar, S.A.; Desai, D.C.; Kshirsagar, R.; Thiagarajan, P.; Agarwal, V. Anticancer activity of Ophiobolin A, isolated from the endophytic fungus Bipolaris setariae. Nat. Prod. Res. 2016, 30, 1455–1458.
62. Bury, M.; Girault, A.; Mégalizzi, V.; Spiegl-Kreinecker, S.; Mathieu, V.; Berger, W.; Evidente, A.; Kornienko, A.; Gailly, P.; Vandier, C.; et al. Ophiobolin A induces paraptosis-like cell death in human glioblastoma cells by decreasing BKCa channel activity. Cell Death Dis. 2013, 4, e561.
63. Morrison, R.; Gardiner, C.; Evidente, A.; Kiss, R.; Townley, H. Incorporation of ophiobolin A into novel chemoembolization particles for cancer cell treatment. Pharm. Res. 2014, 31, 2904–2917.
64. Morrison, R.; Lodge, T.; Evidente, A.; Kiss, R.; Townley, H. Ophiobolin A, a sesterpenoid fungal phytotoxin, displays different mechanisms of cell death in mammalian cells depending upon the cancer cell origin. Int. J. Oncol. 2017, 50, 773–786.
65. Yoshida, N.; Koizumi, M.; Adachi, I.; Kawakami, J. Inhibition of P-glycoprotein-mediated transport by terpenoids contained in herbal medicines and natural products. Food Chem. Toxicol. 2006, 44, 2033–2039.
66. Lv, C.; Qin, W.; Zhu, T.; Wei, S.; Hong, K.; Zhu, W.; Chen, R.; Huang, C. Ophiobolin O isolated from Aspergillus ustus induces G1 arrest of MCF-7 cells through interaction with AKT/GSK3β/Cyclin D1 signaling. Mar. Drugs 2015, 13, 431–443.
67. Dasari, R.; Masi, M.; Lisy, R.; Ferdérin, M.; English, L.R.; Cimmino, A.; Mathieu, V.; Brenner, A.J.; Kuhn, J.G.; Whitten, S.T.; et al. Fungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure-activity relationship and unique pyrrolylation of primary amines. Bioorg. Med. Chem. Lett. 2015, 25, 4544–4548.
68. Xue, D.; Wang, Q.; Chen, Z.; Cai, L.; Bao, L.; Qi, Q.; Liu, L.; Wang, X.; Jin, H.; Wang, J.; et al. 3-Anhydro-6-hydroxy-ophiobolin A, a fungal sesterterpene from Bipolaris oryzae induced autophagy and promoted the degradation of α-synuclein in PC12 cells. Bioorg. Med. Chem. Lett. 2015, 25, 1464–1470.
69. Cabuk, D.; Yetimoglu, E.; Simsek, T.; Gacar, G.; Subasi, C.; Canturk, Z.; Ercin, C.; Karaoz, E.; Uygun, K. The distribution of CD44+/CD24− cancer stem cells in breast cancer and its relationship with prognostic factors. JBUON 2016, 21, 1121–1128.
70. −/low biomarker for screening, diagnosis and monitoring of breast cancer. Oncol. Rep. 2014, 31, 1127–1132.
71. Najumudeen, A.K.; Jaiswal, A.; Lectez, B.; Oetken-Lindholm, C.; Guzmán, C.; Siljamäki, E.; Posada, I.M.D.; Lacey, E.; Aittokallio, T.; Abankwa, D. Cancer stem cell drugs target K-ras signaling in a stemness context. Oncogene 2016, 35, 5248–5262.
72. Kong, A.T.; Chow, L.P. Identification of the binding and inhibition sites in the calmodulin molecule for ophiobolin A by site-directed mutagenesis. Plant Physiol. 1998, 118, 965–973.
73. Linxweiler, M.; Schorr, S.; Schäuble, N.; Jung, M.; Linxweiler, J.; Langer, F.; Schäfers, H.J.; Cavalié, A.; Zimmermann, R.; Greiner, M. Targeting cell migration and the endoplasmic reticulum stress response with calmodulin antagonists: A clinically tested small molecule phenocopy of SEC62 gene silencing in human tumor cells. BMC Cancer 2013, 5, 574.
74. Chidley, C.; Trauger, S.A.; Birsoy, K.; O’Shea, E.K. The anticancer natural product ophiobolin A induces cytotoxicity by covalent modification of phosphatidylethanolamine. Elife 2016, 5, e14601.
75. Rodolfo, C.; Rocco, M.; Cattaneo, L.; Tartaglia, M.; Sassi, M.; Aducci, P.; Scaloni, A.; Camoni, L.; Marra, M. Ophiobolin A induces autophagy and activates the mitochondrial pathway of apoptosis in human melanoma cells. PLoS ONE 2016, 11, e0167672.
76. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646–674.
77. Yang, T.; Lu, Z.; Meng, L.; Wei, S.; Hong, K.; Zhu, W.; Huang, C. The novel agent ophiobolin O induces apoptosis and cell cycle arrest of MCF-7 cells through activation of MAPK signaling pathways. Bioorg. Med. Chem. Lett. 2012, 22, 579–585.
78. Lu, X.H.; Zheng, Z.H.; Ma, Y.; Shi, Y.; Dong, Y.S.; Ren, X.; Mu, D.; Zhang, H.; He, J.G. Factor Xa inhibitors from metabolites of microorganisms. Chin. J. Antibiot. 2007, 32, 277–279.
79. Van Nuffel, A.M.; Sukhatme, V.; Pantziarka, P.; Meheus, L.; Sukhatme, V.P.; Bouche, G. Repurposing drugs in oncology (ReDO)—Clarithromycin as an anti-cancer agent. E Cancer Med. Sci. 2015, 9, 513.
80. Rowley, M.; Tsukamoto, M.; Kishi, Y. Total synthesis of (+)-ophiobolin C. J. Am. Chem. Soc. 1989, 111, 2735–2737.
81. Ruprah, P.K.; Cros, J.P.; Pease, J.E.; Whittingham, W.G.; Williams, J.M.J. Studies towards the total synthesis of cycloaraneosene and ophiobolin M: A general strategy for the construction of the 5–8 bicyclic ring system. Eur. J. Org. Chem. 2002, 2002, 3145–3152.
82. Tsuna, K.; Noguchi, N.; Nakada, M. Convergent total synthesis of (+)-ophiobolin A. Angew. Chem. Int. Ed. 2011, 50, 9452–9455.
83. Tsuna, K.; Noguchi, N.; Nakada, M. Enantioselective total synthesis of (+)-ophiobolin A. Chem. Eur. J. 2013, 19, 5476–5486.
84. Brill, Z.G.; Grover, H.K.; Maimone, T.J. Enantioselective synthesis of an ophiobolin sesterterpene via a programmed radical cascade. Science 2016, 352, 1078–1082.
85. Chiba, R.; Minami, A.; Gomi, K.; Oikawa, H. Identification of ophiobolin F synthase by a genome mining approach: A sesterterpene synthase from aspergillus clavatus. Org. Lett. 2013, 15, 594–597.
86. Narita, K.; Chiba, R.; Minami, A.; Kodama, M.; Fujii, I.; Gomi, K.; Oikawa, H. Multiple oxidative modifications in the ophiobolin biosynthesis: P450 oxidations found in genome mining. Org. Lett. 2016, 18, 1980–1983.
87. Chai, H.Z.; Yin, R.; Liu, Y.F.; Meng, H.Y.; Zhou, X.Q.; Zhou, G.L.; Bi, X.P.; Yang, X.; Zhu, T.H.; Zhu, W.M.; et al. Sesterterpene ophiobolin biosynthesis involving multiple gene clusters in Aspergillus ustus. Sci. Rep. 2016, 6, 27181.